Deborah Rathjen
CEO & Managing Director,
Carina Biotech Limited
Australia
Dr Rathjen is an experienced and respected leader in the biotechnology and pharmaceutical industries within Australia and internationally, and has achieved in excess of $800 million in deals including partnerships with Merck & Co., J&J, Abbott (AbbVie), Celgene, Nycomed (Takeda) and Merck KGaA. An immunologist by training, Dr Rathjen has extensive R&D experience in the areas of infection and immunity, inflammation, oncology and neuroscience, covering multiple treatment modalities. Dr Rathjen has led companies in Europe, US and Australia.
Sessions
-
10-Feb-2025Carina Biotech Limited
)
){kind=logo}
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}